EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY-NC 4.0

Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory study

Francesco Schettini, Alessandra Fontana, Federica Gattazzo, Carla Strina, Manuela Milani, Maria Rosa Cappelletti, Valeria Cervoni, Lorenzo Morelli, Giuseppe Curigliano, Valerio Iebba, Daniele Generali

European Journal of Cancer · 2023-09 · 191 · 112948

DOI: 10.1016/j.ejca.2023.112948 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift European Journal of Cancer, 2023-09. Verfasst von Francesco Schettini und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Hospital Clinic of Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, Fundació …. Hauptthemen laut MEDLINE: Breast Neoplasms, Microbiota. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Università degli Studi di Trieste, Instituto de Salud Carlos III, European Society for Medical Oncology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMicrobiotaHumansFemaleCross-Sectional StudiesProspective StudiesProgression-Free SurvivalErb-b2 Receptor Tyrosine KinasesProtein Kinase InhibitorsAntineoplastic Combined Chemotherapy ProtocolsCyclin-Dependent Kinase 4

Stichwörter der Autor:innen

16S targeted sequencingBiomarkerCyclin-dependent kinase (CDK)4/6-inhibitorsFaecal microbiotaMetagenomic DNAMetastatic breast cancer

Substanzen

Erb-b2 Receptor Tyrosine KinasesProtein Kinase InhibitorsCyclin-Dependent Kinase 4CDK4 protein, human

Autor:innen und Institutionen

  • Medical Oncology Department, Hospital Clinic of Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques Augu…
  • Department for Sustainable Food Process-DiSTAS, Università Cattolica del Sacro Cuore, Piacenza, Italy.
  • Department of Medicine, Surgery and Health Sciences, University of Trieste, Cattinara Hospital, Trieste, Italy.
  • Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy.
  • Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
  • Department of Medicine, Surgery and Health Sciences, University of Trieste, Cattinara Hospital, Trieste, Italy; Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, Cremona, Italy. El…

Förderung

  • Università degli Studi di Trieste
  • Instituto de Salud Carlos III
  • European Society for Medical Oncology

Zitieren

APA

Schettini, F., Fontana, A., Gattazzo, F., Strina, C., Milani, M., Cappelletti, M. R., Cervoni, V., Morelli, L., Curigliano, G., Iebba, V., & Generali, D. (2023). Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory study. European Journal of Cancer, 191, 112948. https://doi.org/10.1016/j.ejca.2023.112948

Vancouver

Schettini F, Fontana A, Gattazzo F, Strina C, Milani M, Cappelletti MR, et al. Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory study. European Journal of Cancer. 2023;191:112948. doi:10.1016/j.ejca.2023.112948

BibTeX
@article{Schettini2023,
  author = {Schettini, Francesco and Fontana, Alessandra and Gattazzo, Federica and Strina, Carla and Milani, Manuela and Cappelletti, Maria Rosa and Cervoni, Valeria and Morelli, Lorenzo and Curigliano, Giuseppe and Iebba, Valerio and Generali, Daniele},
  title = {Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory study},
  journal = {European Journal of Cancer},
  year = {2023},
  volume = {191},
  pages = {112948},
  doi = {10.1016/j.ejca.2023.112948}
}
Kostenlos starten →